MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31.

Income Overview

Net Income
-$1,621K
EPS
-$0.14
Unit: Thousand (K) dollars

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
General and administrative
1,741 11,980* 4,534 4,643
Research and development
61 242* 6,127 6,232
(loss) gain on fair value remeasurement of contingent consideration
--2,361* 4,833 -153
Impairment of right-of-use assets
--2,822* 1,411 -
Total costs and expenses
1,802 11,760 7,239 11,028
Loss from operations
-1,802 -11,760* -7,239 -11,028
Interest income
74 125* 270 407
Interest expense
-210* 963 1,081
Grant income
-1,837* 480 547
Gain on extinguishment of debt
-1,448* --
Other income (expense), net
107 9,661* -112 -
Total other income (expense)
181 12,860* -325 -127
Net gain
-1,099 -7,564 -11,155
Net loss and comprehensive loss
-1,621 ---
Basic EPS
-0.14 0.101 -1.07 -1.71
Diluted EPS
-0.14 0.101 -1.07 -1.71
Basic Average Shares
11,873,568 10,889,260 7,042,457 6,513,108
Diluted Average Shares
11,873,568 10,889,260 7,042,457 6,513,108
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Other income(expense), net$107K Interest income$74K Net loss andcomprehensive loss-$1,621K Total other income(expense)$181K Loss from operations-$1,802K Total costs andexpenses$1,802K General andadministrative$1,741K Research and development$61K

KALA BIO, Inc. (KALA)

KALA BIO, Inc. (KALA)